DYRK2_HUMAN - dbPTM
DYRK2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID DYRK2_HUMAN
UniProt AC Q92630
Protein Name Dual specificity tyrosine-phosphorylation-regulated kinase 2
Gene Name DYRK2
Organism Homo sapiens (Human).
Sequence Length 601
Subcellular Localization Cytoplasm. Nucleus. Translocates into the nucleus following DNA damage.
Protein Description Serine/threonine-protein kinase involved in the regulation of the mitotic cell cycle, cell proliferation, apoptosis, organization of the cytoskeleton and neurite outgrowth. Functions in part via its role in ubiquitin-dependent proteasomal protein degradation. Functions downstream of ATM and phosphorylates p53/TP53 at 'Ser-46', and thereby contributes to the induction of apoptosis in response to DNA damage. Phosphorylates NFATC1, and thereby inhibits its accumulation in the nucleus and its transcription factor activity. Phosphorylates EIF2B5 at 'Ser-544', enabling its subsequent phosphorylation and inhibition by GSK3B. Likewise, phosphorylation of NFATC1, CRMP2/DPYSL2 and CRMP4/DPYSL3 promotes their subsequent phosphorylation by GSK3B. May play a general role in the priming of GSK3 substrates. Inactivates GYS1 by phosphorylation at 'Ser-641', and potentially also a second phosphorylation site, thus regulating glycogen synthesis. Mediates EDVP E3 ligase complex formation and is required for the phosphorylation and subsequent degradation of KATNA1. Phosphorylates TERT at 'Ser-457', promoting TERT ubiquitination by the EDVP complex. Phosphorylates SIAH2, and thereby increases its ubiquitin ligase activity. Promotes the proteasomal degradation of MYC and JUN, and thereby regulates progress through the mitotic cell cycle and cell proliferation. Promotes proteasomal degradation of GLI2 and GLI3, and thereby plays a role in smoothened and sonic hedgehog signaling. Plays a role in cytoskeleton organization and neurite outgrowth via its phosphorylation of DCX and DPYSL2. Phosphorylates CRMP2/DPYSL2, CRMP4/DPYSL3, DCX, EIF2B5, EIF4EBP1, GLI2, GLI3, GYS1, JUN, MDM2, MYC, NFATC1, p53/TP53, TAU/MAPT and KATNA1. Can phosphorylate histone H1, histone H3 and histone H2B (in vitro). Can phosphorylate CARHSP1 (in vitro)..
Protein Sequence MLTRKPSAAAPAAYPTGRGGDSAVRQLQASPGLGAGATRSGVGTGPPSPIALPPLRASNAAAAAHTIGGSKHTMNDHLHVGSHAHGQIQVQQLFEDNSNKRTVLTTQPNGLTTVGKTGLPVVPERQLDSIHRRQGSSTSLKSMEGMGKVKATPMTPEQAMKQYMQKLTAFEHHEIFSYPEIYFLGLNAKKRQGMTGGPNNGGYDDDQGSYVQVPHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPTGEKTSVKRITESTGAITSISKLPPPSSSASKLRTNLAQMTDANGNIQQRTVLPKLVS
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
7Phosphorylation-MLTRKPSAAAPAAY
-CCCCCCCCCCCCCC
33.3128348404
14PhosphorylationSAAAPAAYPTGRGGD
CCCCCCCCCCCCCCH
11.9323312004
16PhosphorylationAAPAAYPTGRGGDSA
CCCCCCCCCCCCHHH
27.1723312004
18MethylationPAAYPTGRGGDSAVR
CCCCCCCCCCHHHHH
48.69-
30PhosphorylationAVRQLQASPGLGAGA
HHHHHHCCCCCCCCC
13.4130266825
40PhosphorylationLGAGATRSGVGTGPP
CCCCCCCCCCCCCCC
33.2130266825
44PhosphorylationATRSGVGTGPPSPIA
CCCCCCCCCCCCCCC
44.0730266825
48PhosphorylationGVGTGPPSPIALPPL
CCCCCCCCCCCCCCC
31.8830266825
98PhosphorylationQQLFEDNSNKRTVLT
EHHHCCCCCCCEEEE
56.9322468782
106PhosphorylationNKRTVLTTQPNGLTT
CCCEEEEECCCCCEE
37.5622817900
136PhosphorylationSIHRRQGSSTSLKSM
HHHHCCCCCCCCHHH
23.3129978859
137PhosphorylationIHRRQGSSTSLKSME
HHHCCCCCCCCHHHC
28.9229978859
138PhosphorylationHRRQGSSTSLKSMEG
HHCCCCCCCCHHHCC
39.5129978859
139PhosphorylationRRQGSSTSLKSMEGM
HCCCCCCCCHHHCCC
35.4329978859
142PhosphorylationGSSTSLKSMEGMGKV
CCCCCCHHHCCCCCC
27.6229978859
292PhosphorylationIHMLENFTFRNHICM
HHHHHHCCCCCCHHH
33.0125690035
309PhosphorylationELLSMNLYELIKKNK
HHHHCCHHHHHHHCC
12.0419664995
331PhosphorylationLVRKFAHSILQCLDA
HHHHHHHHHHHHHHH
22.8929116813
347S-nitrosylationHKNRIIHCDLKPENI
HHCCEEECCCCHHHE
4.6424105792
373S-nitrosylationVIDFGSSCYEHQRVY
EEECCCCHHCHHHHH
5.0424105792
380PhosphorylationCYEHQRVYTYIQSRF
HHCHHHHHHHHHHHH
8.9424260401
381PhosphorylationYEHQRVYTYIQSRFY
HCHHHHHHHHHHHHC
15.9927794612
382PhosphorylationEHQRVYTYIQSRFYR
CHHHHHHHHHHHHCC
4.5419664994
385PhosphorylationRVYTYIQSRFYRAPE
HHHHHHHHHHCCCCH
18.1322617229
442PhosphorylationIELLGMPSQKLLDAS
HHHHCCCCHHHHHHH
30.9322817900
449PhosphorylationSQKLLDASKRAKNFV
CHHHHHHHHHHHHHH
23.4923362280
464PhosphorylationSSKGYPRYCTVTTLS
HCCCCCCEEEEEECC
6.4819664995
466PhosphorylationKGYPRYCTVTTLSDG
CCCCCEEEEEECCCC
16.3829083192
468PhosphorylationYPRYCTVTTLSDGSV
CCCEEEEEECCCCCE
12.1329083192
469PhosphorylationPRYCTVTTLSDGSVV
CCEEEEEECCCCCEE
21.6729083192
471PhosphorylationYCTVTTLSDGSVVLN
EEEEEECCCCCEEEC
37.5229083192
474PhosphorylationVTTLSDGSVVLNGGR
EEECCCCCEEECCCC
17.6529083192
525PhosphorylationWDPAVRMTPGQALRH
CCCCCCCCCCCHHCC
17.4419413330
544PhosphorylationRRLPKPPTGEKTSVK
HCCCCCCCCCCCCEE
67.5128348404
554PhosphorylationKTSVKRITESTGAIT
CCCEEEEHHCCCCEE
28.1028270605
556PhosphorylationSVKRITESTGAITSI
CEEEEHHCCCCEEEH
24.4028270605
557PhosphorylationVKRITESTGAITSIS
EEEEHHCCCCEEEHH
25.1328270605
561PhosphorylationTESTGAITSISKLPP
HHCCCCEEEHHHCCC
21.3428270605
562PhosphorylationESTGAITSISKLPPP
HCCCCEEEHHHCCCC
20.8228270605
564PhosphorylationTGAITSISKLPPPSS
CCCEEEHHHCCCCCC
28.1028270605

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
106TPhosphorylationKinaseATMQ13315
Uniprot
381TPhosphorylationKinaseMLK2Q02779
PSP
442SPhosphorylationKinaseATMQ13315
Uniprot
449SPhosphorylationKinaseMLK2Q02779
PSP
-KUbiquitinationE3 ubiquitin ligaseMDM2Q00987
PMID:19965871
-KUbiquitinationE3 ubiquitin ligaseSIAH2O43255
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
106TPhosphorylation

19965871
106TPhosphorylation

19965871
106Tubiquitylation

19965871
442SPhosphorylation

19965871
442SPhosphorylation

19965871
442Subiquitylation

19965871

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of DYRK2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
FSBP_HUMANRAD54Bphysical
16189514
RA54B_HUMANRAD54Bphysical
16189514
MDM2_HUMANMDM2physical
19965871
UBR5_HUMANUBR5physical
19287380
DDB1_HUMANDDB1physical
19287380
DCAF1_HUMANVPRBPphysical
19287380
GRP78_HUMANHSPA5physical
19287380
HSP7C_HUMANHSPA8physical
19287380
ODO2_HUMANDLSTphysical
19287380
XPP3_HUMANXPNPEP3physical
19287380
RS2_HUMANRPS2physical
19287380
ODPB_HUMANPDHBphysical
19287380
RL7_HUMANRPL7physical
19287380
RL4_HUMANRPL4physical
19287380
HNRPU_HUMANHNRNPUphysical
19287380
SSBP2_HUMANSSBP2physical
19287380
TBA1C_HUMANTUBA1Cphysical
19287380
RLA0_HUMANRPLP0physical
19287380
NPM_HUMANNPM1physical
19287380
MPCP_HUMANSLC25A3physical
19287380
RL7A_HUMANRPL7Aphysical
19287380
HS90A_HUMANHSP90AA1physical
19287380
RT29_HUMANDAP3physical
19287380
TBA3C_HUMANTUBA3Cphysical
19287380
RMXL2_HUMANRBMXL2physical
19287380
RFA1_HUMANRPA1physical
19287380
PIMT_HUMANPCMT1physical
19287380
HSP76_HUMANHSPA6physical
19287380
RL18_HUMANRPL18physical
19287380
KTNA1_HUMANKATNA1physical
19287380
SIAH2_HUMANSIAH2physical
22878263
A4_HUMANAPPphysical
21832049
TERT_HUMANTERTphysical
23362280
DYRK4_HUMANDYRK4physical
23602568
TITIN_HUMANTTNphysical
23602568
RBCC1_HUMANRB1CC1physical
23602568
NR1I2_HUMANNR1I2physical
24438055
IKZF1_HUMANIKZF1physical
25416956
KXDL1_HUMANKXD1physical
25416956
LZTS2_HUMANLZTS2physical
25416956
ZBTB9_HUMANZBTB9physical
25416956
WDR62_HUMANWDR62physical
25416956
UB2D1_HUMANUBE2D1physical
23362280
DCAF5_HUMANDCAF5physical
19287380
TBK1_HUMANTBK1physical
26407194
RNF8_HUMANRNF8physical
28194753
SAV1_HUMANSAV1physical
27173435
KIF3C_HUMANKIF3Cphysical
27173435
KIF3B_HUMANKIF3Bphysical
27173435
UBR5_HUMANUBR5physical
28242748
DCAF1_HUMANVPRBPphysical
28242748
DDB1_HUMANDDB1physical
28242748
CEP78_HUMANCEP78physical
28242748

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of DYRK2_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"ATM augments nuclear stabilization of DYRK2 by inhibiting MDM2 in theapoptotic response to DNA damage.";
Taira N., Yamamoto H., Yamaguchi T., Miki Y., Yoshida K.;
J. Biol. Chem. 285:4909-4919(2010).
Cited for: SUBCELLULAR LOCATION, PHOSPHORYLATION AT THR-106 AND SER-442 BY ATM,UBIQUITINATION BY MDM2, INTERACTION WITH MDM2, MUTAGENESIS OF THR-106;SER-442 AND 189-LYS--ARG-191, NUCLEAR LOCALIZATION SIGNAL, ANDINDUCTION BY DNA DAMAGE.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-382, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-382, AND MASSSPECTROMETRY.

TOP